The project of
The foundation stone laying ceremony of a hi-tech pharm complex “Hayat Pharm” was held in Pirallahi industrial estate near Baku, Azerbaijan, on November 2nd, 2016.
In order to carry out the project a joint venture was established by the following shareholders:
The project involves implementation of advanced technological solutions, equipment and engineering techniques of the leading European companies. The preliminary overall investment volume exceeds EURO 70 million. The production is expected to reach its full capacity by the end of 2019.
Hayat Pharm joint venture is a long term project focused on provision of drug safety in Azerbaijan, public supply with high quality local pharm products, reduction of imported medicinal drugs and development of export potential. The pharm products to be produced at the enterprise are expected to be sold both in the domestic market and in the neighboring counties. Over 200 high capacity workplaces will be established within the project.
Drugs belonging to various pharm groups are planned to be produced at Hayat Pharm, including oncological, antifungal, antiemetic, antiviral agents, anti-HIV therapy, drugs for the treatment of nervous disorders and diseases of cardiovascular, musculoskeletal and respiratory systems as well as antibiotics, antidiabetic medications, radiopaque contrast agents and magnetic resonance contrast agents. In total 89 types of medicines and 58 international generics will be manufactured at the enterprise. The plant capacity will be 22,5 million packages or 500 million tablets and capsules.